Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Grows By 50.0%
Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Grows By 50.0%
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 45,900 shares, an increase of 50.0% from the August 15th total of 30,600 shares. Based on an average daily trading volume, of 1,913,000 shares, the days-to-cover ratio is currently 0.0 days.
Q BioMed Inc.(場外交易代碼:QBIO-GET Rating)8月份空頭股數銷量大幅增長。截至8月31日,空頭股數共有4.59萬股,比8月15日的3.06萬股增加了50.0%。基於日均成交量1,913,000股,目前天數與回補比率為0.0天。
Q BioMed Stock Performance
Q BioMed股票表現
QBIO remained flat at $0.02 during trading on Friday. 69,167 shares of the company's stock traded hands, compared to its average volume of 396,902. Q BioMed has a 12 month low of $0.02 and a 12 month high of $0.76. The stock's 50-day moving average is $0.05 and its 200 day moving average is $0.13. The stock has a market capitalization of $1.41 million, a price-to-earnings ratio of -0.08 and a beta of 2.39.
在週五的交易中,QBIO持平於0.02美元。該公司股票成交量為69,167股,而其平均成交量為396,902股。Q BioMed的12個月低點為0.02美元,12個月高位為0.76美元。該股的50日移動均線切入位在0.05美元,200日移動均線切入位在0.13美元。該股市值為141萬美元,市盈率為-0.08倍,貝塔係數為2.39。
Q BioMed (OTCMKTS:QBIO – Get Rating) last announced its earnings results on Thursday, July 28th. The company reported ($0.06) earnings per share for the quarter. The firm had revenue of $0.17 million for the quarter.
Q BioMed(OTCMKTS:QBIO-GET Rating)上一次公佈財報是在7月28日(星期四)。該公司公佈了本季度每股收益(0.06美元)。該公司本季度的收入為17萬美元。
Q BioMed Company Profile
Q BioMed公司簡介
Q BioMed Inc, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain.
Q BioMed Inc.是一家生物醫學加速和開發公司,專注於許可、收購和向生命科學和醫療保健公司提供資源。該公司提供氯化鍶SR89和美沙酮,這是一種治療轉移性骨癌疼痛的放射性藥物。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Q BioMed (QBIO)
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
- Is There a Cure for What is Ailing Teladoc Stock?
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It's a Down Week
- 免費獲取有關Q BioMed(QBIO)的StockNews.com研究報告
- 股市:紅海中的三座強國
- 第四季度值得考慮的3家銀行
- 有什麼辦法可以治癒Teladoc股票的問題嗎?
- MarketBeat:回顧一週9/12-9/16
- 沒有人告訴這三隻股票這是下跌的一週
Receive News & Ratings for Q BioMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed and related companies with MarketBeat.com's FREE daily email newsletter.
接受Q BioMed Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Q BioMed和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。